FDA Clearance Tracker · P050012-S016
DEXCOM SEVEN SYSTEM
Last checked: Nov 20, 2026Latest source record: Feb 13, 2009 (this decision)Source: openFDAMethods & limitations
Decided
Feb 13, 2009
Approved
Time to decision
193 days
Received Aug 4, 2008. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P050012-S016
- Device name
- DEXCOM SEVEN SYSTEM
- Applicant
- Dexcom, Inc.
- Applicant location
- San Diego, CA
- Received
- Aug 4, 2008
- Decided
- Feb 13, 2009
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P050012
Device type
- Device type
- Sensor, glucose, invasive (MDS)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR MODIFICATIONS TO THE RECEIVER USER INTERFACE AND ALGORITHM, AND MODIFICATIONS TO THE TRANSMITTER TO MAKE IT COMPATIBLE TO THE MODIFIED RECEIVER ALGORITHM.
Source documents
Other decisions for Dexcom, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262472 · Decided Aug 11, 2026 · 25 days after receipt
Device type: Integrated Continuous Glucose Monitor For Non-Intensive Glucose Management, Over-The-Counter (SBH) · Laboratory Medicine & Pathology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.